Venetoclax and Daratumumab combination treatment demonstrates pre-clinical efficacy in mouse models of Acute Myeloid Leukemia (2021)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1186/s40364-021-00291-y
PubMed Identifier: 33985565
Publication URI: http://europepmc.org/abstract/MED/33985565
Type: Journal Article/Review
Parent Publication: Biomarker Research
Issue: 1
ISSN: 2050-7771